Progabide: A Controlled Trial in Partial Epilepsy
- 1 April 1983
- Vol. 24 (2), 127-134
- https://doi.org/10.1111/j.1528-1157.1983.tb04873.x
Abstract
Progabide (SL 76002) was studied in a randomized double-bond crossover trial using 20 outpatients suffering from partial complex seizures. Progabide was added to the concomitant antiepileptic treatment in a fixed dosage schedule. The design included an open therapy control unit. No significant difference was established between the number of partial seizures during treatment with progabide and placebo. A trend was observed for lower seizure frequency of secondary generalized seizures during treatment with progabide. Only mild and transient side effects were observed. There was no difference between the side effects of progabide and placebo.Keywords
This publication has 14 references indexed in Scilit:
- Controlled Trials in Epilepsy: A ReviewEpilepsia, 1982
- Amino acid abnormalities in epileptogenic fociNeurology, 1981
- Inhibitory, GABAergic Nerve Terminals Decrease at Sites of Focal EpilepsyScience, 1979
- GAMMA-AMINOBUTYRIC ACID AND THE SEARCH FOR NEW ANTICONVULSANT DRUGSThe Lancet, 1978
- A micro liquid column chromatography procedure for twelve anticonvulsants and some of their metabolitesJournal of Chromatography B: Biomedical Sciences and Applications, 1978
- The in vivo inactivation of GABA and other inhibitory amino acids in the cat nervous systemExperimental Brain Research, 1976
- Effects of Anticonvulsant Drugs on the Cerebral Enzymes Metabolizing GABAEpilepsia, 1975
- 328. Note: The Use of None-Parametric Methods in the Statistical Analysis of the Two-Period Change-Over DesignPublished by JSTOR ,1972
- EFFECTS OF DI‐n‐PROPYLACETATE, AN ANTICONVULSIVE COMPOUND, ON GABA METABOLISM1Journal of Neurochemistry, 1969
- Quantitative Determination of Barbiturates *). A modified spectrophotometric method for clinical use.Acta Pharmacologica et Toxicologica, 1950